Emyria Ltd News

Emyria Ltd: Emyria Shares Interim Success in PTSD Treatment Program

Sep 2 07:50

Emyria Ltd: June 2024 Quarterly Activities Report and Appendix 4C

Jul 30 07:06

Emyria Ltd: Emyria, UWA Secure $499K Grant for MDMA Analogue Program

Jul 1 07:30

Emyria Ltd: Empax Centre Selected As Key Site In Global PTSD Study

Jun 20 06:21

Emyria Ltd: Management Changes

Jun 11 06:22

Emyria Ltd: March 2024 Quarterly Activities Report and Appendix 4C

Apr 26 06:40

Emyria Ltd: Trading Halt

Apr 19 07:14

Emyria Ltd: Emyria Opens Empax Centre to Advance Mental Health Care

Apr 10 06:23

Emyria Ltd: Emyria Expands Specialist AP Team - First Female for MDMA-AT

Apr 5 05:25

Emyria Ltd: Emyria, Reach Wellness Enter MDMA-AT Research Agreement

Apr 3 05:25

Emyria Ltd: Response to ASX Aware Query

Mar 12 14:58

Emyria Ltd: Response to ASX Price Query

Mar 8 06:56

Emyria Ltd: December 2023 Quarterly Activities Report and Appendix 4C

Jan 31 06:32

Emyria Ltd: Emyria Receives $2.5M R&D Tax Incentive Refund

Jan 15 06:29

Emyria Ltd: Emyria Specialist Granted Authorised Prescriber Status

Jan 10 06:28

Emyria Ltd: Change of Director's Interest Notice - M. Winlo

Jan 2 16:43

Emyria Ltd: Initial Director's Interest Notice - G. Hutchinson

Nov 22, 2023 05:59

Emyria Ltd: Final Director's Interest Notice - S. Washer

Nov 22, 2023 05:58

Emyria Ltd: Eminent Healthcare Leader New Independent Non-Exec Chair

Nov 21, 2023 06:45

Emyria Ltd: Final Director's Interest Notice - A. Vickery

Nov 13, 2023 15:47